Last reviewed · How we verify

NCT04238494: MIDAS

Muscle Multi-parametric NMR Imaging Development in Aged People With Sarcopenia or Frailty Syndrome; CLINical Study

Status unknown NA Last updated 20 October 2021
What this trial tests

NA trial testing Nuclear magnetic resonance (NMR) in Frail Elderly Syndrome in 60 participants. Status unknown.

Timeline
18 October 2019
Primary endpoint
30 May 2022
30 May 2022

Quick facts

Lead sponsorUniversity Hospital, Bordeaux
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposeother
Enrollment60
Start date18 October 2019
Primary completion30 May 2022
Estimated completion30 May 2022
Sites2 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Bordeaux

Who can join

Adults 70 to 90, any sex, with Frail Elderly Syndrome or Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Frailty is a multideterminant syndrome in which muscle function appears to play a central role. Muscle function depends on brain control, nutrition and perfusion. We hypothesized that multiparametric MRI assessment combined with comprehensive gerontological assessment (CGA) and routine biological assessment of inflammation in a sample of older people with and without diabetes will allow to explore on one side the possibilities of multi-parametric MRI muscle and brain imaging to describe the correlates of frailty and on the other side will describe the different muscle/brain alterations due to diabetes in frailty. The main objective is to compare the lipid percent of the rectus femoris in frail and pre-frail older subjects and in non-frail older subjects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Frail Elderly Syndrome

Currently open trials in the same condition.

Other University Hospital, Bordeaux trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04238494.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing